Abstract:OBJECTIVE:To observe the analgesic effect of intrathecal transplant of immortalized rat astrocyte genetically modified by human preproenkephalin gene (IAST/hPPE) on chronic neuropathic pain. METHODS:40 adult male Sprague-Dawley rats were randomly divided into four groups, 10 rats for each group. Naive group, SNI group, SNI + IAST group and SNI + IAST/hPPE group. The immortalized rat astrocyte (IAST) or IAST/hPPE co-incubated with bromodeoxyuridine (BrdU) in vitro were transplanted in the lumbar 4 to 6 subarachnoid space near the spinal cord 1 week after right side spared nerve injury (SNI). All animals were tested for bilateral 50% hindpaw withdrawal threshold (PWT) to a graded series of Von Frey hairs stimulation once a week from one week before SNI to six weeks after transplant, the difference value for right 50% PWT minus left 50% PWT was calculated and the effect of intraperitoneal naloxone on the analgesic efficacies was also observed. The content of L-EK in the spinal cord of L4 - 6 and was determined using immunohistochemistry and radioimmunoassay, and the expression of BrdU in grafts was determined using immunohistochemistry. RESULTS:Allodynia-like behaviour after 1 week following SNI was observed. As compared with Naive group, the difference value for the right 50% PWT minus left 50% PWT in the other three groups was higher significantly (P < 0.01). The tactile allodynia induced by SNI was significantly alleviated during the 1 to 6 week period after transplantation of IAST/hPPE cells, but transplants of IAST cells had no effect on the allodynia-like behaviour. The difference value for the right 50% PWT minus left 50% PWT in SNI + IAST/hPPE group was lower significantly than that in the SNI and SNI +I AST group (P < 0.01), but there was no significant difference between SNI and SNI + IAST group (P > 0.05). The efficacies were reversed by intraperitoneal naloxone in SNI + IAST/hPPE group. The content of L-EK in the lumbar spinal cord in IAST/hPPE group (108.1 pg/mg +/- 12.5 pg/mg) was significantly higher than that in other three groups (P < 0.01), but there was no significant difference between SNI and SNI + IAST group (25.4 pg/mg +/- 1.9 pg/mg vs 28.0 pg/mg +/- 2.1 pg/mg, P > 0.05). Furthermore, The grafts in the surface of dorsal horn were still stained positively for BrdU, they survived greater than 6 weeks on the pia mater around the spinal cord. CONCLUSION:Intrathecal transplant of IAST/hPPE cells could alleviate the allodynia-like behaviour after chronic neuropathic pain, which is associated with enkephalin secreted continuously from the grafts and conducted via opiate receptors.

Lumbar Transplantation of Immortalized Enkephalin-Expressing Astrocytes Attenuates Chronic Neuropathic Pain.

[Analgesic Effect of Intrathecal Transplant of Immortalized Rat Astrocyte Strain Genetically Modified by Human Preproenkephalin Gene on Rat Chronic Neuropathic Pain].

ESTABLISHMENT OF AN IMMORTALIZED RAT ASTROCYTE STRAIN EXPRESSING ENKEPHALIN REGULATED BY DOXYCYCLINE AND ITS ANALGESIC EFFECT ON RAT CHRONIC NEUROPATHIC PAIN

Subarachnoid Transplantation of Immortalized Galanin‐overexpressing Astrocytes Attenuates Chronic Neuropathic Pain

Effect of sciatic nerve pulsed radiofrequency glial activation levels in spinal dorsal horn in chronic constriction injury rat models and its analgesia effect

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Immortalized Bone Mesenchymal Stromal Cells With Inducible Galanin Expression Produce Controllable Pain Relief in Neuropathic Rats

Intrathecal Bone Marrow Stromal Cells Inhibit Neuropathic Pain Via TGF-β Secretion.

Intrathecal Implantation of Microencapsulated PC12 Cells Reduces Cold Allodynia in a Rat Model of Neuropathic Pain.

Electroacupuncture and Lumbar Transplant of GDNF-secreting Fibroblasts Synergistically Attenuate Hyperalgesia after Sciatic Nerve Constriction.

Intrathecal transplantation of neural stem cells appears to alleviate neuropathic pain in rats through release of GDNF.

Intrathecal xenogeneic chromaffin cell grafts reduce nociceptive behavior in a rodent tonic pain model

Construction of an immortalized rat astrocyte strain with inducible enkephalin expression

Transplantation of Microencapsulated Olfactory Ensheathing Cells Inhibits the P2X2 Receptor Over-Expressionmediated Neuropathic Pain in the L4-5 Spinal Cord Segment

Cell transplantation as a pain therapy targets both analgesia and neural repair.

Subarachnoid implantation of microencapsulated PC12 cells reduces cold allodynia in a rat model of neuropathic pain

Microencapsulated Schwann Cell Transplantation Inhibits P2X2/3 Receptors Overexpression in a Sciatic Nerve Injury Rat Model with Neuropathic Pain

Effects of Intrathecal Transfection of Recombinant Adenovirus Containing Human Beta-nerve Growth Factor Gene with Enchanced Green Fluorescent Proteinon on Expression of Dorsal Root Ganglion Substance P and Calcitonin Gene-related Peptide in Rats with Neuro

Subarachnoid transplant of a human neuronal cell line attenuates chronic allodynia and hyperalgesia after excitotoxic spinal cord injury in the rat

Microencapsulated Olfactory Ensheathing-Cell Transplantation Reduces Pain in Rats by Inhibiting P2X4 Receptor Overexpression in the Dorsal Root Ganglion

Microencapsulated Schwann Cell Transplantation Inhibits P2X3 Receptor Expression in Dorsal Root Ganglia and Neuropathic Pain.